ITC Rules Apple Watches Do Not Infringe Masimo Patents
A U.S. trade judge ruled that Apple's redesigned smartwatches do not violate Masimo's blood-oxygen patents. The decision rejects a bid for a new import ban.
Xurve View
Insights:
Xurve View
A trade tribunal in the United States has issued a preliminary ruling in favor of Apple Inc., finding that the company's current smartwatch models do not infringe on patents held by Masimo Corporation. This decision rejects a bid for a renewed import ban on the devices, following a long-standing legal battle over medical-monitoring technology. Apple previously modified its watches to bypass an import ban issued by the International Trade Commission (ITC) in 2023, and an ITC judge has now agreed that these redesigned versions do not violate Masimo's patent rights.
